Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ideaya Biosciences Inc
(NQ:
IDYA
)
42.65
+1.30 (+3.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Ideaya Biosciences Inc
< Previous
1
2
3
4
Next >
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
May 24, 2023
Via
Benzinga
Analyst Expectations for IDEAYA Biosciences's Future
May 24, 2023
Via
Benzinga
Recap: IDEAYA Biosciences Q1 Earnings
May 09, 2023
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
IDEAYA Biosciences: Q1 Earnings Insights
May 09, 2023
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
IDEAYA Biosciences's Return On Capital Employed Insights
March 09, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 28, 2022
December 28, 2022
Via
Benzinga
Where IDEAYA Biosciences Stands With Analysts
October 27, 2022
Analysts have provided the following ratings for IDEAYA Biosciences (NASDAQ:IDYA) within the last quarter:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 24, 2023
Via
Benzinga
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 24, 2023
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.
Via
Benzinga
Nasdaq Turns Lower Ahead Of Big Week For Tech
April 24, 2023
The Nasdaq Composite Index has begun to slip deeper into the red ahead of this week's slew of Big Tech earnings.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023
April 24, 2023
Via
Benzinga
IDEAYA Biosciences Touts Encouraging Data From Combo Therapy For Rare Eye Cancer Impacting Around 14,000 In US and Europe
April 24, 2023
Via
Benzinga
US Stocks Edge Higher; Coca-Cola Posts Upbeat Results
April 24, 2023
U.S. stocks traded slightly higher this morning, with the Dow Jones gaining around 30 points on Monday. Following the market opening Monday, the Dow traded up 0.10% to 33,843.10 while the NASDAQ rose...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 24, 2023
Via
Benzinga
Philips, Credit Suisse And Other Big Stocks Moving Higher In Monday's Pre-Market Session
April 24, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023
March 23, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
February 28, 2023
Via
Benzinga
Buy/Sell: Wall Street's Top 5 Stock Calls This Week - Sunday, Jan. 1
January 01, 2023
What was Wall Street buzzing about this past week? Let's take a closer look at the top 5 buy calls made by Wall Street’s best analysts during the week of Dec. 26-30, 2022.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2022
October 27, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 15, 2022
Via
Benzinga
Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket
September 15, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.
Via
Benzinga
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
September 16, 2022
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
September 15, 2022
Good morning! It's time for another dive into the biggest pre-market stock movers as we see why shares are moving Thursday morning!
Via
InvestorPlace
Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session
September 15, 2022
Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome...
Via
Benzinga
Arconic, Rhythm Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
September 15, 2022
U.S. stock futures traded higher this morning ahead of several economic reports. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Why Ideaya Biosciences Shares Are Falling Sharply During Wednesday's After-Hours Session
September 14, 2022
Ideaya Biosciences Inc (NASDAQ: IDYA) shares are trading lower by 10.07% to $11.25 during Wednesday's after-hours session. The company announced an $80 million common stock offering.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 14, 2022
Gainers Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million.
Via
Benzinga
Where IDEAYA Biosciences Stands With Analysts
September 13, 2022
Over the past 3 months, 4 analysts have published their opinion on IDEAYA Biosciences (NASDAQ:IDYA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...
Via
Benzinga
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
September 13, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 12, 2022
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.